A Richmond realtor is trying to position themselves as a go-to resource for the burgeoning home-grown marijuana scene.

Eric Morehouse of real estate company The Morehouse Group has launched The Key RVA, offering advice and assistance, planting and growing kits to people who want to grow marijuana at home in light of the new laws of the country. ‘State.

The company’s service area consists of Richmond, Henrico and Chesterfield. He has three entrepreneurs who visit clients at their homes to provide services.

The Key charges $ 115 for home visits during which contractors can service, harvest, dry and process client’s marijuana. The company also sells indoor grow kits starting at $ 500 and offers plant care when customers are away from home.

Morehouse said he has about a dozen regular customers who use plant care and growth support services. Morehouse is the only full employee of the home business, which currently serves as a side gig. He runs The Morehouse Group with his wife Colleen.

The Key also operates an online store through Amazon where people can purchase pots, soil, and other growing accessories, and he pockets a fee for referrals. Morehouse said he plans to have local retailers featured on The Key’s website.

Morehouse said that while he knows a thing or two about growing marijuana, his personal contributions to the business are focused on management, sales and marketing.

He said he designed The Key after meeting people who were interested in growing marijuana at home, but were unsure how to go about it.

“As I was touring through these cannabis-friendly events, I found myself surrounded by (people who were) mostly 55 and over, and more women than men, wondering how to start,†he said. -he declares. “I was like, ‘Wow, there is already a need for people to get questions answered.’ “

The personal use and personal cultivation of marijuana was legalized for adults in July. By law, individuals are allowed to grow up to four marijuana plants per household for their own use.

The new law has spawned other new businesses in town, including cannabis growing supplier Happy Trees Agricultural Supplies, which recently moved into a new warehouse in Northside.

In other recent cannabis movements, local medical cannabis supplier Green Leaf Medical has started selling marijuana buds and joints for smoking.

Posted: November 19, 2021 / 4:49 PM CST
/ Update: November 19, 2021 / 4:49 PM CST

ST. LOUIS – A cannabis-infused seltzer is on the market at several medical marijuana dispensaries in the St. Louis area. The locally made low dose infused seltzer is called “Society”.

The product is manufactured by Monarch Supply Company. The seltzer is the first of its kind to originate from Missouri. It will be available to medical cannabis patients statewide by early 2022.

Seltzer is made from citrus and tropical ingredients, infused with a tasteless extract in a micro-dose of 5 milligrams of THC.

The drinks are available in three flavors: cherry blossom, blood orange and ginger and lime. The company claims that they are also fast acting and contain 15 calories.

Society comes in a stylish, weathered, resealable 12-ounce tin, and sells for $ 7.

Monarch is a St. Louis-based business and is owned and operated by a local team with 70 years of combined experience in both traditional beer leadership and building craft beer brands.

“Our combined beer and cannabis experience gives our Society beverage portfolio an edge and an advantage,†said Doug Mars, director of operations for Monarch, in a press release.

Prior to Monarch, Mars had a 26-year career with Anheuser-Busch. Most recently, he served as the general manager of a local high-production independent craft brewery and managed the first retail licensed medical dispensary in the early adopted state of Illinois in the Midwest.

Monarch CEO Corey Christanell says the company is appealing to broader trends as well, including as an alternative for millennials and baby boomers who are ditching sugary drinks and drinking less alcohol.

The name “Society” recognizes how sociable an infused drink is, reflecting the brand’s commitment to making cannabis socially acceptable.

Because “the purpose†is a core value of Monarch, the company’s beverage portfolio includes a social impact initiative called Support A Purpose. Support a Purpose is designed to advance the collective efforts of the cannabis community to destigmatize the plant, while allowing customers to fund donations in partnership with their hometown dispensaries for their hometown charities.

Total sales for Missouri’s medical marijuana program hit $ 200 million – and the state is getting its share.

Just 14 months ago, the first sale took place at a licensed medical marijuana dispensary in Missouri. In September of this year, monthly cannabis sales topped $ 20 million for the first time, and in November total sales hit less than $ 26 million.

The $ 200 million total includes a 4% retail tax on marijuana, which means state coffers have benefited from $ 8 million. There are 158,169 qualified patients (which equates to about 2% of the state’s total population), so total sales average $ 1,264 per patient – with just over $ 50 for the state. The money does not go into general revenue because it was allocated to veterans services.

According to the Missouri Department of Health and Seniors’ Services, more than 300 medical cannabis establishments are now operating in the state in various sectors; including growers, manufacturers, dispensaries, testing laboratories, transporters and suppliers of seeds for sale.

To purchase medicinal cannabis, residents of Missouri need a medical certificate indicating that they have one or more of the nearly two dozen qualifying conditions, including a chronic medical condition causing severe and persistent pain or shortcomings. persistent muscle spasms.

A doctor can certify a patient to acquire up to four ounces of dried, unprocessed marijuana, or its equivalent, in a 30-day period. However, if a patient requires a higher amount, two independent physician certifications are required to justify it.

In total, there will be 192 dispensaries in Missouri – but properly registered patients or their caregivers can grow up to six flowering plants, six non-flowering plants and six clones at a time. There is an additional charge for this privilege – an additional $ 100 – and safety rules that must be followed.

The Department seems quite proud of its efforts to roll out the state agenda.

“The national average for implementation is 29 months, and Missouri was able to implement its medical program in just over 23 months,†DHSS said last week. “Only five states implemented medical programs faster than Missouri (Pennsylvania, New York, Utah, Minnesota and Oklahoma).”

More information on Missouri’s medical cannabis program can be found here.

Columbia Care Completes Acquisition of Colorado-based Medicine Man; Strengthens its leadership position in the world’s second largest cannabis market

• Adds four Denver-Metro retail outlets and 35,000 square foot indoor grow facility
• Immediately accelerate Columbia Care’s adjusted EBITDA and operating cash flow
• Solidifies Columbia Care’s Position as the Leading Retailer, Grower and Manufacturer in Colorado

NEW YORK, November 1, 2021– (BUSINESS WIRE) –Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care†or the “Companyâ€), one of largest and most experienced cannabis growers, manufacturers and distributors in the United States, today announced that it has completed the acquisition of Medicine Man, a leading, vertically integrated cannabis company based in the United States. Colorado, which has served the Denver metro area since 2009.

The total initial consideration was $ 42.0 million, including $ 8.4 million in cash and $ 33.6 million in shares, with the possibility of an additional milestone payment based on 2021 performance. The transaction is immediately accretive to Adjusted EBITDA and operating cash flows. The initial consideration of $ 42.0 million represents a multiple of approximately 4.5 times the EBITDA forecast for 2021.

As the second largest cannabis market in the world, Colorado has become a global indicator for adult use programs and continues to show strong organic growth. The acquisition of Medicine Man strengthens our leadership position in the state by combining us with a recognized operator that has consistently outperformed the Colorado market since its inception.

Nicholas Vita, CEO of Columbia Care

We are grateful to the cities of Aurora, Denver and Thornton, and the State of Colorado, for their support, and to the team at Medicine Man who have been great to work with throughout this process. Our vision and values ​​are aligned, and we look forward to expanding our Columbia Care family with the addition of those who have made Medicine Man such a successful business.

The acquisition adds a culture facility and four dispensaries to Columbia Care’s operations in Colorado, including the location of Medicine Man Longmont, which is expected to close in the first quarter of 2022. Columbia Care’s Colorado footprint will now total 26 dispensaries and six growing and manufacturing facilities, including those under the The Green Solution brand.

This marks the next step in the evolution of Medicine Man from an ambitious family business to part of a blue chip operation. Our experience with Columbia Care through this process reinforced the reasons we decided to partner with them.

Sally Vander Veer, CEO of Medicine Man

The team has been amazing, fair and efficient over the past few months. Our goal now is to implement their vision and bring as much value as possible to Operation Columbia Care.

For more information on the transaction, please refer to Columbia Care’s Press release published on June 15, 2021, or visit the presentations section of the investor site.

Advisors

Foley Hoag LLP is legal counsel for Columbia Care. Right Side Advisory Services acts as financial advisor to Medicine Man. Husch Blackwell LLP is acting as legal counsel to Medicine Man.

About Columbia Care

Columbia Care is one of the largest and most experienced cultivators, manufacturers and suppliers of cannabis products and related services, with licenses in 18 US jurisdictions and the EU. Columbia Care operates 130 facilities, including 99 dispensaries and 31 growing and manufacturing facilities, including those under development. Columbia Care is one of the premier providers of medical cannabis in the United States and now offers cutting-edge products and services to both the medical and adult markets. In 2021, the company launched Cannabist, its new retail brand, creating a nationwide network of dispensaries that operate proprietary technology platforms. The company offers products including flowers, edibles, oils and tablets, and manufactures popular brands such as Seed & Strain, Triple Seven, gLeaf, Classix, Plant Sugar, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit www.col-care.com.

Original press release

Get ahead by signing up to 420 Investor, the largest and most comprehensive premium subscription service for cannabis traders and investors since 2013.

Posted by NCV Newswire

New Cannabis Ventures’ NCV Newswire aims to curate high quality content and information on leading cannabis companies to help our readers filter the noise and stay on top of the most important news in the cannabis market. The NCV Newswire is organized by hand by a publisher and is by no means automated. Do you have confidential topical advice? Get in touch.

Receive our Sunday newsletter

---

Following media reports that children with epilepsy have benefited from medical marijuana (or medical cannabis products) available abroad, the UK government has allowed clinicians to prescribe these products.

A review published in Childhood developmental medicine and neurology explores the science behind cannabis-based drugs in pediatric epilepsies and highlights areas that warrant further research.

The authors also examined the prescribing environment surrounding these products. They found that the lack of quality evidence for efficacy and safety is the main obstacle to prescribing.

They stress that unauthorized cannabis-based drugs should not circumvent usual regulatory requirements before being prescribed. And they fear that children with epilepsy could be used as a “Trojan horse” for the cannabis industry, with the widespread acceptance of medicinal cannabis accelerating the wider legalization of marijuana and opening up a very lucrative commercial market.

Americas News, NEW YORK, NY, Sat Sep 18, 2021: Here are the cannabis headlines making cannabis news around the world, the Caribbean and Latin America for today, September 18, 2021 in 60 seconds:

Drake, Meek Mill, Killer Mike and 2 Chainz along with professional athletes Deion Sanders and Kevin Garnett are among a host of celebrities who have written to President Biden to seek clemency for federal cannabis offenders.

Montego Bay, Jamaica-based medical cannabis dispensary Outlier has joined efforts to get Jamaicans vaccinated against COVID-19 with the new ‘Weed for Vaccine’ campaign, which it hopes will grow. smokers to queue for the jab. Outlier follows in the footsteps of companies offering discounts and / or gifts to people who have been vaccinated.

The World Anti-Doping Agency (WADA) will conduct a scientific review of marijuana next year to determine whether it should maintain an international ban on cannabis use by athletes.

Radiant Canna has obtained the exclusive rights to select Marley Natural® cannabis products in California and allows Radiant to produce and distribute Marley Natural cannabis flowers, concentrates and edibles.

The Pennsylvania Senate Transportation Committee will consider a proposal next week that shieExcludes medical cannabis users from state-imposed “zero tolerance†penalties for impaired driving.

Afro-Latina Shamor Belliard is the originator of the eco-friendly and affordable CBD beauty brand, Just Beauty CBD.

New market research published by Global Industry Analysts Inc., (GIA) predicts that the “Cannabis Beverages†market will reach US $ 2 billion by 2026.

Investors looking to enter the Barbados cannabis business now have it easy with all the necessary services under one roof, those of Invest Caribbean and Ritzury at investcaribbeannow.com.

And three cannabis stocks to look out for this week are: Flora Growth Corp. (FLGC), Greenlane Holdings Inc. (GNLN) and Lowell Farms Corp Sub Vtg Sh (LOWLF).

In the quest to change US cannabis laws, the House of Representatives has not been a big deal. The challenge has always come with the US Senate.

Last week, however, Senate Majority Leader Chuck Schumer unveiled a bill to decriminalize marijuana at the federal level that he wants to bring to the Senate. The bill already has the support of Senate Finance Committee Chairman Ron Wyden (D-Ore.).

With the potential for major federal cannabis reform underway, is it time to stock up on marijuana stocks?

Image source: Getty Images.

Many potential winners

As you might expect, there are a lot of potential winners if marijuana is decriminalized federally in the United States. Canadian cannabis producers have long wanted to penetrate the huge market south of the border. However, they cannot do so and list their shares on the major US stock exchanges while cannabis remains illegal at the federal level.

If this roadblock is removed, Canopy growth (NASDAQ: CGC) stands out as a particularly likely beneficiary. Canopy already has an option to acquire a US-based cannabis operator Area of ​​assets. It has a major partner (and largest shareholder) based in the United States – Constellation brands. Canopy could be the first to enter the US market if the bill proposed by Senator Schumer becomes law.

Don’t overlook the opportunities for companies currently operating in the United States, however. Cresco Laboratories (OTC: CRLBF), for example, ranks among the most valued multi-state cannabis operators. One of the reasons Cresco shares are cheap compared to most Canadian pot stocks is that the company cannot list its shares on a major US stock exchange.

It’s a similar story for Trulieve Cannabis (OTC: TCNNF), one of the largest cannabis operators in the United States. If Trulieve traded at the same price / sell multiple as Canopy Growth, its market cap would reach $ 10.3 billion, significantly more than its current market cap of $ 6 billion.

The Senate snag

Senator Schumer’s support for federal cannabis reform removes a major obstacle from the past. When the GOP controlled the Senate, former Senate Majority Leader Mitch McConnell would not even have considered introducing a bill for major cannabis reform in the Senate.

However, there is still a big potential problem in the Senate. Any bill before the House can be delayed by a single senator who chooses to use filibuster. As a result, Senator Schumer needs 60 votes to pass his bill. It is not clear that these votes can be garnered at the moment.

The Senate is divided 50-50 between Democrats and Republicans (including two independents who align with the Democrats). This means that 10 GOP votes would be needed to avoid an obstruction if all Democrats and Independents voted as a bloc.

Polls show the American public supports cannabis reform. Thirty-five states have legalized medical and / or recreational marijuana. However, there is no guarantee that a sufficient number of Senators will vote with the views of their constituents on this issue.

Do not back up the truck just yet

With such political uncertainty in the Senate, investors are unlikely to back down and stock up on marijuana stocks just yet. This does not mean, however, that there are no individual actions worthy of close examination.

I’ve mentioned two cannabis stocks before that seem like good choices no matter what happens in Washington, DC Cresco Labs continues to grow in its core markets. He also moved to new states including Florida and Ohio.

Trulieve already dominates the medical cannabis market in Florida. The company is poised for a bigger and better future with its impending acquisition of Harvest Health and leisure.

Another stock that I particularly like is Innovative industrial properties (NYSE: IIPR). The company is a real estate investment trust (REIT) that focuses on the US medical cannabis market. In some ways, the IIP might be better off if federal cannabis reform is not passed. However, even if the proposed legislation manages to garner enough votes for victory, I still believe that the IIP will be able to generate solid growth for years to come.

Here’s the marijuana stock you’ve been waiting for
A little-known Canadian company has just unlocked what some experts believe is the key to profiting from the upcoming marijuana boom.

And make no mistake, it does happen.

Cannabis legalization is sweeping across North America – 15 states plus Washington, DC, have all legalized recreational marijuana in recent years, and full legalization arrived in Canada in October 2018.

And an under-the-radar Canadian business is about to explode because of this upcoming marijuana revolution.

Because a game-changing deal has just been struck between the Government of Ontario and this mighty corporation … and you must hear this story today if you’ve even considered investing in pot stocks. .

Just click here to get the full story now.

Learn more

Keith Speights owns shares of Innovative Industrial Properties. The Motley Fool owns shares and recommends Constellation Brands, Cresco Labs Inc., Innovative Industrial Properties and Trulieve Cannabis Corp. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The New Mexico Department of Regulation and Licensing and its Cannabis Control Division heard from the public Thursday in a public regulatory hearing regarding cannabis couriers, retail establishments and manufacturing facilities.

Comments during the meeting ranged from regulatory proposals for packaging requirements, from general business practices to deliveries of cannabis to businesses and residences. Katy Duhigg, an Albuquerque-based cannabis lawyer, raised a series of issues she would like to see changed and offered specific suggestions. Duhigg is also a New Mexico state senator, but said she does not speak in her capacity as a lawmaker.

Duhigg took issue with the proposed requirement that cannabis manufacturers must prove that they have access to water rights, because manufacturing does not necessarily use water in the same way as growing.

“To require all manufacturers to prove water rights for their application, I think, is unreasonably onerous, because that just won’t be a factor for a number of them,†Duhigg said.

During the special legislative session surrounding the Cannabis Regulation Act, lawmakers added a provision that cannabis growers, who are often referred to as producers, must show they have legal access to water. after many members of the public expressed concerns about New Mexico’s scarcity of water supply.

Duhigg also said she was concerned about a provision that would prevent cannabis retailers from giving free products to anyone except medical cannabis patients.

“I think companies should be allowed to make the business decision to offer free products if they want to,†said Duhigg. “It should be tracked and accounted for, but I don’t think there is a compelling government interest in restricting who companies can give their products away for free.”

Duhigg also suggested that the ministry reconsider a proposed rule that would limit deliveries of cannabis to residential addresses. She said this would place an “unreasonable burden” on couriers to decide what qualifies as a residence.

“It will reduce cannabis tourism to New Mexico, and there is no compelling government interest in doing so,” Duhigg said. “Companies can set their own policies around cannabis. This is an unreasonable restriction.

Tony Martinez of cannabis company Lava Leaf Organics raised concerns over a proposed rule that would require cannabis delivery vehicles to be fitted with an additional box or cage in addition to the standard vehicle locks. . Martinez said that drivers who currently deliver medical cannabis to retail outlets depend on their speed and imperceptibility for security and that securing and unsecuring locks will lengthen delivery time and place drivers in a vulnerable place.

“I would like people to recognize how dangerous it can be to manipulate a second set of locks that are inside the trunk, the back of the vehicle, etc.,†Martinez said. “What appears to create additional security really just creates additional risk.”

In addition to the public comments made during the hearing, a handful of people submitted their comments online.

Kristina Caffrey, lawyer for prominent New Mexico medical cannabis producer Ultra Health, submitted comments on behalf of the company.

Among Ultra Health’s list of concerns was one of the requirements for what is known in the industry as closed loop extractions. A common process for making cannabis extracts is to use a volatile solvent like butane to remove elements from the cannabis plant material. A closed loop extraction process includes a separate, sealed chamber where solvents can be removed from the cannabis concentrate.

Caffrey wrote that a requirement that manufacturers use a “commercially manufactured” closed-loop system is ambiguous.

“It’s not clear enough what ‘commercially made’ means,” Caffrey wrote. “Does a manufacturer have to purchase a fully assembled system from a commercial supplier? Or can the licensee buy parts and assemble them himself? Can the licensee buy a used system? And which supplier qualifies as a commercial manufacturer? “

Maggie’s Farm, a Colorado cannabis company, suggested a number of changes, including one to allow circulation in dispensaries. There is currently at least one medical cannabis dispensary in New Mexico with drive-thru, but New Mexico years ago cut in-car liquor stores in an effort to combat drinking and driving. .

One person who submitted their comments online said RLD should change the proposed requirements to allow concentrates to have more than 30 percent THC by weight.

Melinda Pineda, policy officer for the state’s social services division, submitted a comment online suggesting that commercial cannabis licenses be revoked if the owner violates a child support order.

“It is the position of the Child Support Enforcement Division of the Department of Social Services that the Cannabis Regulation Act does not conflict with the Parental Responsibility Act, and it is intended that the Department of Regulation and Licensing will deny or suspend cannabis establishment licenses and producer licenses for individuals. who do not comply with child support orders and / or procedures, â€Pineda wrote.

A common feeling at the start of the hearing was that the department could have done a better job with technology that allows virtual public comment.

The hearing was held virtually out of caution for COVID-19, but for about the first hour of the meeting, all but two of the people struggled to go through the meeting’s application.

While Wendy Robbins, producer of the The marijuana show, provided she had substantive comments on the proposed rules and regulations, by the time she was able to pass, she also had some pointed comments on RLD using WebEx instead of the now popular Zoom for Audience.

“I’d like it to be recorded as you go from WebEx, which was popular in the ’70s or’ 80s, to Zoom, where even my grandmother could ride,†Robbins said.

Gama Mendez, who operates a delivery app, raised concerns over proposed requirements for locking cannabis in a delivery vehicle, but first raised concerns about the difficult start of the meeting.

“It’s pretty sad that we’re all invested in this,†Mendez said. “I’m really disappointed that you’ve had so much time, and we can’t get an ‘unmute’ button.”

Another commentator, Miguel De Santigo, said he needed to be reminded of the topic of the meeting as there was such a delay in registering people.

“I can’t remember exactly what we’re supposed to be commenting on publicly because of everything we’ve been trying to figure out,†De Santiago said.

But after the technical difficulties, the comments focused more on the proposed rules themselves.

RLD and the Cannabis Control Division may make changes based on the comments submitted, but are not obligated to do so.

Assuming the changes that RLD and the Cannabis Control Division decide to make are consistent with the original purpose of the proposed rules, the department will not need to hold an additional hearing before enacting them.

Once the rules are finalized and RLD Superintendent Linda Trujillo approves them, they will come into effect and the state can begin accepting licenses for manufacturers, couriers and outlets.

Related

Unsurprisingly, college towns have high cannabis retail densities, said Michelle Donovan, senior counsel for Detroit-based Clark Hill PLC, which specializes in licensing, regulations and other cannabis-related issues.

She pointed the finger at Ann Arbor as well as Kalamazoo and Adrian – not only the headquarters of Adrian College, but also near the border with Ohio, which only approved medical cannabis.

From the start, some small towns saw cannabis as an opportunity to create much needed new economic activity, said Travis Copenhagen, a cannabis lawyer based in Ann Arbor and Vicente Sederberg LLP.

Copenhagen mentioned Bay City, whose rules allow 50 retailers in the municipality with a population of 33,000. Lansing, with a population of over 117,000, will host up to 28. Little Vassar with less than 3,000 residents has four active licensees and authorizes one recreational retailer per medical license holder.

While Michigan’s cannabis industry is undoubtedly booming, Donovan said there is still a glaring lack of availability relative to demand.

“You’re good if you’re in a college town, that’s for sure. That doesn’t make it accessible to, you know, someone who might live in northern Macomb County… where are they going to go? Donovan said.

Delivery can fill some of those gaps – the Lapeer County dispensary, Pure Lapeer, for example, delivers 60 miles from its store and which includes much of Macomb County.

The world’s first nationally adopted cannabis software will help standardize, simplify and propel the federally-run medical cannabis industry in Saint-Vincent and the Grenadines

DENVER, August 5, 2021 / PRNewswire / – Akerna Company (Nasdaq: KERN) today announces an exclusive partnership with the Medicinal Cannabis Authority (MCA) in Saint-Vincent-et-les- Grenadines (SVG). As part of this partnership, Akerna will provide MCA with a customer relationship management (CRM) tool specially developed to strengthen the medicinal cannabis industry in the Caribbean countries while meeting regulatory requirements and creating a user-friendly experience. This program will serve as a national model that can be replicated to meet all global cannabis regulations.

This program will serve as a national model that can be replicated to meet all global cannabis regulations.

The medicinal cannabis industry at SVG exists within parameters and mandates defined by local laws and international traceability treaties that govern controlled substances. These parameters require precise monitoring of medicinal cannabis which, combined with the requirements for authorization of personal possession, require significant documentation that must be completed for each patient.

The CRM implemented by Ample Organics, an Akerna company, is expected to dramatically simplify this documentation process and enable rapid assessment of the patient access platform, improving data retrieval, data availability for the patient. MCA and an overall physician, pharmacist and patient friendly experience.

“After seeing the success of Akerna’s Ample Organics product in Canada, the Medicinal Cannabis Authority of SVG was interested in partnering to create software to meet their specific regulatory and compliance needs, â€said Jessica billingsley, CEO of Akerna. “This is the first-ever implementation of a nationwide CRM system within the cannabis industry and will serve as a model for other countries or regions looking to implement a standardized system to nationwide. ”

“The new workflows will provide a better organization of information and increase the efficiency of monitoring and analysis processes, reducing the need for time, paper and human resources, in order to maximize productivity,” said said dr. Jerrol thompson, CEO of the Medicinal Cannabis Authority. “The MCA wanted to express its sincere thanks to Ample Organics and the rest of the Akerna family for guiding SVG through the various challenges of starting a cannabis market, allowing us to reach this successful stage today. ”

Saint-Vincent and the Grenadines strives to be the best regulated medicinal cannabis industry in the world Caribbean, with high quality products recognized for local use and for export, which meet the highest international and industrial standards. The vision of the cannabis industry in SVG integrates the entire value chain of this drug, including Good Agricultural and Collection Practices (GACP), Good Manufacturing Processes (GMP), export and l local patient access. The industry was designed to maximize its impact on the Vincentian workforce and economy and is expected to be an important driver of technological innovation and contribute to the growth of the agricultural, industrial, medical and tourism sectors.

About Ample Organics:

Founded in 2014 and acquired by Akerna in 2020, Ample Organics is adopted by more Canadian licensees than any other cannabis software solution. A complete ecosystem for cannabis companies, the technology platform facilitates compliance by tracking individual plants from seed to consumer and reporting every detail of the growth, production and sales processes. Our team of cannabis industry and tech experts designed the platform to facilitate compliance and transparency while improving overall business efficiency and operational intelligence. The software continues to be the most reliable solution for cannabis growers, manufacturers, distributors, physicians, clinics, laboratories, retailers and educators. Visit AmpleOrganics.com.

About Akerna:

Akerna (Nasdaq: KERN) is a service-oriented enterprise software company compliant with the cannabis, hemp, and CBD industries. Situated at Denver, Colorado, the company’s mission is to create the world’s most transparent and responsible supply chain by creating a cannabis technology ecosystem connecting data points across the global supply chain for cannabis, seed for sale to oneself. First launched in 2010, Akerna has followed more than $ 20 billion in cannabis sales to date and was the first cannabis software company listed on the Nasdaq.

Using connected data and information to power the cannabis industry, Akerna empowers businesses, governments, patients and consumers to make smart decisions. The company’s core technology, the MJ Platform, the world’s leading infrastructure as a service platform, powers retailers, manufacturers, brands, distributors and growers. Akerna also offers a full suite of professional consulting and data analysis services for business as well as solo science, MJ Freeway, Leaf Data Systems, Trellis, Ample Organics and Viridian Sciences.

About the Medicinal Cannabis Authority:

The Medicinal Cannabis Authority was created under the Medicinal Cannabis Industry Act, 2018. It is a legal person with the mandate to regulate the cultivation, supply, possession, production and use of cannabis for medical purposes. This mandate is part of the government of Saint-Vincent and the Grenadines vision to establish a well-regulated and export-oriented medicinal cannabis industry. Visit MCA.VC.

Saint-Vincent and the Grenadines has established a well-regulated, high-quality, export-oriented medicinal cannabis industry. He strives to be a leader and an example of how a small nation with big dreams, ideas and well-designed plans can successfully establish a world-class medicinal cannabis industry. A critical part of this is the local availability of medicinal cannabis for local patients and visitors with appropriate eligible diseases and to do so in a very efficient and professional manner.

Forward-looking statements

Certain statements made in this press release and any accompanying statements by management are “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, words “estimates”, “plans”, “expects”, “anticipates”, “plans”, “plans”, “intention”, “believes”, “research”, “may”, “may”, “should” , “Should”, “the future”, “propose” and variations of such similar words or phrases (or negative versions of such words or phrases) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the CRM implemented by Ample which are expected to significantly simplify the documentation process and enable rapid assessment of the Patient Access Platform, improving data retrieval. , availability of data for the MCA and overall user-friendly experience and any other statements expressing the views of Akerna management on future business results or strategy. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond the control of ‘Akerna, which could lead to actual results or results. (including, without limitation, the results of Akerna’s contracts, strategic initiatives and business plans as described herein) differ materially from those discussed in the forward-looking statements. Important factors, among others that may affect results or actual results, include (i) Akerna’s ability to recognize the expected benefits of being a public company, (ii) competition, (iii) ability of Akerna to grow and manage its growth profitably, (iv) Akerna’s ability to maintain customer and supplier relationships and retain its management and key employees, (v) costs associated with to be a public company, (vi) changes in applicable laws or regulations, (vii) Akerna’s ability to identify, complete and integrate acquisitions, including Viridian, and achieve expected synergies and operational efficiencies in in connection with the acquired businesses, (viii) and other risks and uncertainties disclosed from time to time in the documents filed by Akerna with the United States Securities and Exchange Commission, including those mentioned in section n “Risk factorsâ€. Actual results, performance or achievements may differ materially, and potentially negatively, from any projections and forward-looking statements and the assumptions on which they differ from forward-looking statements. There can be no assurance that the data contained in this document reflects to any degree future performance. You are cautioned not to place undue reliance on forward-looking statements as predictors of future performance, as projected financial and other information is based on estimates and assumptions which are inherently subject to various risks, uncertainties and other important factors, including many are beyond Akerna’s control. All information contained herein is valid only as of the date hereof, in the case of information about Akerna, or as of the date of such information, in the case of information from persons other than Akerna. Akerna assumes no obligation to update or revise the information contained in this document. Forecasts and estimates for Akerna’s industry and end markets are based on sources believed to be reliable; however, there can be no assurance that such forecasts and estimates will prove to be correct in whole or in part.

View original content to download multimedia: https://www.prnewswire.com/news-releases/akerna-secures-worlds-first-national-government-cannabis-contract-with-st-vincent-and-the-grenadines -301349313 .html

SOURCE Akerna